B. Metzler Seel. Sohn & Co. Holding Ag Moderna, Inc. Transaction History
B. Metzler Seel. Sohn & Co. Holding Ag
- $10.1 Trillion
- Q3 2024
A detailed history of B. Metzler Seel. Sohn & Co. Holding Ag transactions in Moderna, Inc. stock. As of the latest transaction made, B. Metzler Seel. Sohn & Co. Holding Ag holds 22,673 shares of MRNA stock, worth $969,270. This represents 0.02% of its overall portfolio holdings.
Number of Shares
22,673
Previous 8,617
163.12%
Holding current value
$969,270
Previous $3.32 Million
45580.95%
% of portfolio
0.02%
Previous 0.05%
Shares
5 transactions
Others Institutions Holding MRNA
# of Institutions
1,022Shares Held
242MCall Options Held
9.07MPut Options Held
13.1M-
Baillie Gifford & CO42.5MShares$1.82 Billion2.17% of portfolio
-
Vanguard Group Inc Valley Forge, PA39.6MShares$1.69 Billion0.09% of portfolio
-
Black Rock Inc. New York, NY25.6MShares$1.09 Billion0.07% of portfolio
-
State Street Corp Boston, MA15MShares$642 Million0.08% of portfolio
-
Theleme Partners LLP London, X07.23MShares$309 Million42.67% of portfolio
About Moderna, Inc.
- Ticker MRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 391,200,000
- Market Cap $16.7B
- Description
- Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...